These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11694909)

  • 1. Irritable bowel syndrome: new approaches to its pharmacological management.
    Tougas G
    Can J Gastroenterol; 2001 Oct; 15 Suppl B():12B-13B. PubMed ID: 11694909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
    Scarpignato C; Pelosini I
    Can J Gastroenterol; 1999 Mar; 13 Suppl A():50A-65A. PubMed ID: 10202210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment of the irritable bowel syndrome and other functional bowel disorders.
    Mearin F
    Digestion; 2006; 73 Suppl 1():28-37. PubMed ID: 16498250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug treatment of the irritable bowel syndrome.
    Pattee PL; Thompson WG
    Drugs; 1992 Aug; 44(2):200-6. PubMed ID: 1382014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tegaserod: a review of its use in the management of irritable bowel syndrome with constipation in women.
    Wagstaff AJ; Frampton JE; Croom KF
    Drugs; 2003; 63(11):1101-20. PubMed ID: 12749744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Symptomatic therapy of irritable bowel syndrome. Which drug for which symptoms?].
    Madisch A; Hotz J
    MMW Fortschr Med; 2001 Sep; 143(39):28-30. PubMed ID: 11680924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritable bowel syndrome: new pharmaceutical approaches to treatment.
    Farthing MJ
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):461-71. PubMed ID: 10580922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic therapy for the irritable bowel syndrome.
    Talley NJ
    Am J Gastroenterol; 2003 Apr; 98(4):750-8. PubMed ID: 12738451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky.
    Horwitz BJ
    Health News; 2002 Oct; 8(10):1-2. PubMed ID: 12416480
    [No Abstract]   [Full Text] [Related]  

  • 10. Tegaserod: a novel, selective 5-HT4 receptor partial agonist for irritable bowel syndrome.
    Beglinger C
    Int J Clin Pract; 2002; 56(1):47-51. PubMed ID: 11831835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatment options for irritable bowel syndrome: managing for success.
    Dunphy RC; Verne GN
    Drugs Aging; 2001; 18(3):201-11. PubMed ID: 11302287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meteospazmil and its place in treating patients with irritable bowel syndrome].
    Minushkin ON
    Eksp Klin Gastroenterol; 2002; (1):94-7. PubMed ID: 12271597
    [No Abstract]   [Full Text] [Related]  

  • 13. [Irritable colon].
    Meier R; Meyer M; Degen L
    Ther Umsch; 1997 Nov; 54(11):654-60. PubMed ID: 9454369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome.
    Kellow J; Lee OY; Chang FY; Thongsawat S; Mazlam MZ; Yuen H; Gwee KA; Bak YT; Jones J; Wagner A
    Gut; 2003 May; 52(5):671-6. PubMed ID: 12692051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Irritable bowel syndrome: diagnostic criteria and recent advancement of its pharmacological management].
    Matsueda K
    Nihon Shokakibyo Gakkai Zasshi; 2001 Oct; 98(10):1146-53. PubMed ID: 11680988
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of Debridat in treating the irritable bowel syndrome].
    Parfenov AI
    Voen Med Zh; 1996 May; 317(5):37-8. PubMed ID: 8754091
    [No Abstract]   [Full Text] [Related]  

  • 17. [New drug for irritable bowel syndrome].
    Hennemann A
    Med Monatsschr Pharm; 2001 Apr; 24(4):106-8. PubMed ID: 11338633
    [No Abstract]   [Full Text] [Related]  

  • 18. New drugs in the management of the irritable bowel syndrome.
    Farthing MJ
    Drugs; 1998 Jul; 56(1):11-21. PubMed ID: 9664195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alosetron (Lotronex) is back: should I use it to treat my patients with irritable bowel syndrome?
    Shen B; Soffer EE
    Cleve Clin J Med; 2003 Jan; 70(1):64-5. PubMed ID: 12549728
    [No Abstract]   [Full Text] [Related]  

  • 20. Updated review of current pharmacological and non-pharmacological management of irritable bowel syndrome.
    Rawla P; Sunkara T; Raj JP
    Life Sci; 2018 Nov; 212():176-181. PubMed ID: 30290187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.